Photrexa is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Glaukos Corporation. The primary component is Riboflavin 5'-phosphate Sodium Anhydrous.
| Product ID | 25357-023_030af81d-5c28-44e7-8386-6c5b3f569af0 |
| NDC | 25357-023 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Photrexa |
| Generic Name | Riboflavin 5-phosphate Ophthalmic |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2016-04-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA203324 |
| Labeler Name | Glaukos Corporation |
| Substance Name | RIBOFLAVIN 5'-PHOSPHATE SODIUM ANHYDROUS |
| Active Ingredient Strength | 1 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2016-04-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA203324 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2016-04-15 |
| Ingredient | Strength |
|---|---|
| RIBOFLAVIN 5'-PHOSPHATE SODIUM | 1.46 mg/mL |
| SPL SET ID: | f82cfe92-1a24-11e3-8ffd-0800200c9a66 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 25357-023 | Photrexa | riboflavin 5-phosphate ophthalmic |
| 25357-025 | Photrexa Cross-linking Kit | riboflavin 5-phosphate ophthalmic |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PHOTREXA 85849014 4724270 Live/Registered |
Avedro Inc. 2013-02-13 |